Back to search
FDAFDA · Food and drugs·Recall number Z-0801-2013

The product is a lyophilized growth supplement for use with dehydrated culture media to prepare BCYE Medium used for isolation of Legionellae from clinical and environmental samples.

Published February 20, 2013 · Recall initiated: October 10, 2012

Summary

FDA records medical device Class II recall Z-0801-2013, published February 20, 2013 and initiated October 10, 2012. Recalling firm: Remel Inc; Status: Terminated; Reported quantity: 10 units; Lot: Lot 1175209. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The product may contain low level microbial contamination which could result in incorrect results.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Remel Inc
Distributor
Distribution included the states of IL, IN and MI.
Lot
Lot 1175209
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was The product is a lyophilized growth supplement for use with dehydrated culture media to prepare BCYE Medium used for isolation of Legionellae from clinical and environmental samples. recalled?

Yes. FDA published recall Z-0801-2013 on February 20, 2013. Reported hazard: The product may contain low level microbial contamination which could result in incorrect results.

What should I do if I have this product?

Voluntary: Firm initiated · Letter